Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ArcticZymes Technologies ASA ( (DE:B4V) ) just unveiled an announcement.
ArcticZymes Technologies ASA has completed a share buy-back program to support its Employee Share Purchase Program, selling 31,365 treasury shares to employees at a 15% discount. The transaction, which involves a one-year lock-up period, saw participation from several primary insiders, indicating strong internal confidence in the company’s future prospects.
More about ArcticZymes Technologies ASA
Headquartered in Tromsø, Norway, ArcticZymes Technologies ASA is a publicly listed company specializing in the provision of novel and high-quality enzymes for molecular research, diagnostics, and biomanufacturing. With over 30 years of experience, the company focuses on developing enzymes inspired by the Arctic environment, ensuring robust performance under challenging conditions. ArcticZymes is ISO 13485 certified and adheres to ICH GMP standards.
Average Trading Volume: 40,484
Current Market Cap: NOK1.08B
For a thorough assessment of B4V stock, go to TipRanks’ Stock Analysis page.